Menu
1-702-720-6310 info@microcapspecualtors.com

Seattle biotech M3 raises $12M for clinical trial of Alzheimer’s treatment – The Seattle Times


The Seattle Times

Seattle biotech M3 raises $12M for clinical trial of Alzheimer’s treatment
The Seattle Times
Seattle-based M3 Biotechnology has raised $12 million from investors to start clinical trials for a drug that seeks to reverse the effects of Alzheimer’s disease. The startup has licensed technology that’s been developed over more than a decade at

Search